This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Crown Bioscience, Inc. (Taicang). Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Zhu Mei - Innovator in Cancer Research
Introduction
Zhu Mei is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of cancer research, particularly in the development of methods for predicting the responsiveness of cancer cells to specific inhibitors.
Latest Patents
Zhu Mei holds a patent titled "Methods for determining responsiveness to MEK/ERK inhibitors." This innovative method predicts the responsiveness of a cancer cell to an MEK inhibitor by detecting mutations in genes such as ADAM12, COL14A1, TNN, and TP53. The presence of these mutations indicates a decreased responsiveness of the cancer cell to the ERK inhibitor, providing valuable insights for targeted cancer therapies.
Career Highlights
Zhu Mei is currently employed at Crown Bioscience, Inc., located in Taicang. His work focuses on advancing cancer treatment methodologies through innovative research and development.
Collaborations
Zhu collaborates with notable colleagues, including Sheng Guo and Wubin Qian, to further enhance the impact of their research in the field of oncology.
Conclusion
Zhu Mei's contributions to cancer research through his patented methods exemplify the importance of innovation in medical science. His work continues to pave the way for improved cancer treatment strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile